Category Archives: patient education

Locating the Human Ghost in the Digital Machine

By Clark Herman | Published: October 18, 2012

Featured panelists at ExL’s annual Digital Pharma East conference this week included practicing physicians, vocal ePatients, social media gurus and digital marketing consultants with plenty of hours logged in big pharma boardrooms.

Also posted in E-Media, Events, Marketing, Patient Communication, People, Sales, Strategy, Technology, social media | Tagged digital marketing, Digital Pharma East, ePatient, Quantified Self | 1 Comment

As American as Acid Reflux

By Ben Comer | Published: August 21, 2012

Over the counter drug advertising is less regulated than prescription drug marketing, and selling directly to consumers comes with the benefit of bypassing an expert middleman: your doctor. But companies should still promote with caution.

Also posted in Advertising, Corporate Responsibility, E-Media, FDA, Market Access, Marketing, Regulatory, Strategy, healthcare, leadership | Tagged Agency, celebrity, Consumer Advertising, Marketing and Advertising, OTC, Publicis | 1 Comment

The Increasing Value of Medical Science Liaisons

By Ben Comer | Published: August 3, 2012

Can’t get your sales rep into that academic medical center? Try sending a medical science liaison (MSL). A new study from Industry Standard Research (ISR) found that MSLs enjoy better access and higher levels of trust among oncologists. Docs also want different kinds of information from MSLs, according to the study findings.

Also posted in Advertising, Marketing, Medical Education, Sales, Strategy | Tagged ISR, Medical Science Liaison, MSL | 2 Comments

Challenges in the March Toward an AIDS-Free Generation

By Ben Comer | Published: August 1, 2012

FDA’s approval of Truvada, a once-a-day oral combination of tenofovir and emtricitabine, for pre-exposure prophylaxis (or PrEP, a method for preventing HIV infection) arrived during a chorus of optimism surrounding major developments in the fight against AIDS.

Also posted in Biotech, Events, FDA, Market Access, Patient Communication, Regulatory, Safety, healthcare, patient compliance, pricing | Tagged AIDS, Antiretroviral drug, Bill & Melinda Gates Foundation, conference, Gilead Sciences, HIV, HIV/AIDS, NIAID | Leave a comment

Missed Opportunities in Rare Disease

By Ben Comer | Published: July 20, 2012

At CBI’s 7th Annual Rare Disease and Orphan Drug Leadership Congress, speakers and attendees identified areas where pharma can improve the way it approaches rare disease and treatment.

Also posted in Corporate Responsibility, Events, Market Access, Regulatory, leadership, patient compliance | Tagged CBI, orphan diseases, Orphan Drugs, rare diseases, REMS | Leave a comment